Apogenix, which spun out from the German Cancer Research Center, the largest biomedical research institute, raised €7.5m ($9.6m) in a round led by Apogenix investor Dievini Hopp BioTech, the life sciences investment firm of Germany-based software company SAP co-founder Dietmar Hopp. The round was also participated in by the German Cancer Research Center. Apogenix is…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
